Abstract
Both host carbogen (95% oxygen/5% carbon dioxide) breathing and nicotinamide administration enhance tumour radiotherapeutic response and are being re-evaluated in the clinic. Non-invasive magnetic resonance imaging (MRI) and 31P magnetic resonance spectroscopy (MRS) methods have been used to give information on the effects of nicotinamide alone and in combination with host carbogen breathing on transplanted rat GH3 prolactinomas. Gradient recalled echo (GRE) MRI, sensitive to blood oxygenation changes, and spin echo (SE) MRI, sensitive to perfusion/flow, showed large signal intensity increases with carbogen breathing. Nicotinamide, thought to act by suppressing the transient closure of small blood vessels that cause intermittent tumour hypoxia, induced a small increase in blood oxygenation but no detectable change in perfusion/flow. Carbogen combined with nicotinamide was no more effective than carbogen alone. Both carbogen and nicotinamide caused significant increases in the nucleoside triphosphate/inorganic phosphate (βNTP/Pi) ratio, implying that the tumour cells normally receive sub-optimal substrate supply, and is consistent with either increased glycolysis and/or a switch to more oxidative metabolism. The most striking observation was the marked increase in blood glucose (twofold) induced by both nicotinamide and carbogen. Whether this may play a role in tumour radiosensitivity has yet to be determined. Copyright 2000 Cancer Research Campaign. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Al-Hallaq HA, River JN, Zamora M, Oikawa H and Karczmar GS (1998) Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 41: 151–159
Ammon HPT and Estler CJ (1967) The effect of nicotinic acid on glycolytic carbohydrate breakdown in the liver. Life Sci 6: 641–647
Bates S, Yetkin Z, Jesmanowicz A, Hyde JS, Bandettini PA, Estkowski L and Haughton VM (1995) Artifacts in functional magnetic resonance imaging from gaseous oxygen. J Magn Reson Imaging 5: 443–445
Bergmeyer HU (1974). Methods of Enzymatic Analysis. Verlag Chemie: Weinheim
Bernier J, Denekamp J, Rojas A, Trovo M, Horiot JC, Hamers H, Antognoni P, Dahl O, Richaud P, Kaanders J, van Glabbeke M and Pierart M (1999) ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC. Radiother Oncol 52: 149–156
Bhujwalla ZM, Tozer GM, Field SB, Maxwell RJ and Griffiths JR (1990) The energy metabolism of RIF-1 tumours following hydralazine. Radiother Oncol 19: 281–291
Bhujwalla ZM, Shungu DC, He Q, Wehrle JP and Glickson JD (1994) MR studies of tumors: relationship between blood flow, metabolism and physiology. In: NMR in Physiology and Biomedicine. Gillies RJ (ed), pp. 311–328, Academic Press: San Diego
Biaglow JE, Manevich Y, Leeper D, Chance B, Dewhirst MW, Jenkins WT, Tuttle SW, Wroblewski K, Glickson JD, Stevens C and Evans SM (1998) MIBG inhibits respiration: potential for radio- and hyperthermic sensitization. Int J Radiat Oncol Biol Phys 42: 871–876
Braun RD, Lanzen JL and Dewhirst MW (1999) Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am J Physiol 277: H551–H568
Brown SL, Ewing JR, Kolozsvary A, Butt S, Cao Y and Kim JH (1999) Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration. Int J Radiat Oncol Biol Phys 43: 627–633
Chaplin DJ, Olive PL and Durand RE (1987) Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 47: 597–601
Chaplin DJ, Horsman MR and Trotter MJ (1990) Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst 82: 672–676
Chaplin DJ, Horsman MR and Aoki DS (1991) Nicotinamide, Fluosol DA and carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer 63: 109–113
Dewhirst MW, Vinuya RZ, Ong ET, Klitzman B, Rosner G, Secomb TW and Gross JF (1992) Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature. Radiat Res 130: 345–354
Dewhirst MW, Snyder S, Lanzen J, Braun RD, Secomb TW and Biaglow J (1999) Hyperglycemia plus hyperoxia improves tumor oxygenation more efficiently than hyperoxia alone. Proc Int Soc Oxygen Transport Tiss 36,
Dunn JF, Frostick S, Adams GE, Stratford IJ, Howells N, Hogan G and Radda GK (1989) Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study. FEBS Lett 249: 343–347
Dunn JF and Swartz HM (1997) Blood oxygenation: heterogeneity of hypoxic tissues monitored using BOLD MR imaging. In: Oxygen Transport in Tissue XIX, Harrison and Delpy (eds), pp. 645–650, Plenum Press: New York
Duyn JH, Moonen CTW, van Yperen GE, de Boer RW and Luyten PR (1994) Inflow versus deoxyhaemoglobin effects in ‘BOLD’ functional MRI using gradient echoes at 1.5T. NMR Biomed 7: 83–88
Eddy HA and Cassarett GW (1973) Development of the vascular system in the hamster malignant neurilemoma. Microvasc Res 6: 63–82
Gray LH, Conger AD, Ebert M, Hornsey S and Scott OCA (1956) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638–648
Griffiths JR, Taylor NJ, Howe FA, Saunders MI, Robinson SP, Hoskin PJ, Powell MEB, Thoumine M, Caine LA and Baddeley H (1997) The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39: 697–701
Guyton AC and Hall JE (1996). Textbook of Medical Physiology WB Saunders: Philadelphia
Hirst DG, Joiner B and Hirst VK (1993) Blood flow modification by nicotinamide and metoclopramide in mouse tumours growing in different sites. Br J Cancer 67: 1–6
Horsman MR (1995) Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncol 34: 571–587
Horsman MR, Chaplin DJ and Brown JM (1987) Radiosensitization by nicotinamide in vivo: a greater enhancement of tumor damage compared to that of normal tissues. Radiat Res 109: 479–489
Horsman MR, Brown JM, Hirst VK, Lemmon MJ, Wood PJ, Dunphy EP and Overgaard J (1988) Mechanism of action of the selective tumor radiosensitiser nicotinamide. Int J Radiat Oncol Biol Phys 15: 685–690
Hoskin PJ, Saunders MI, Phillips H, Cladd H, Powell MEB, Goodchild K, Stratford MRL and Rojas A (1997) Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br J Cancer 76: 260–263
Howe FA, Robinson SP and Griffiths JR (1996) Modification of tumour perfusion and oxygenation monitored by gradient recalled echo MRI and 31P MRS. NMR Biomed 9: 208–216
Howe FA, Robinson SP, Rodrigues LM and Griffiths JR (1999) Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumours to carbogen breathing. Magn Reson Imaging 17: 1307–1318
Jirtle R (1988) Chemical modification of tumour blood flow. Int J Hyperthermia 4: 355–371
Kaanders JHAM, Pop LAM, Marres HAM, Liefers J, van den Hoogen FJA, van Daal WAJ and van der Kogel AJ (1998) Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol 48: 115–122
Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K and Dewhirst MW (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56: 5522–5528
Kjellen E, Joiner MC, Collier JM, Johns H and Rojas A (1991) A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol 22: 81–91
Menke H and Vaupel P (1988) Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. Radiat Res 114: 64–76
Moreno FJ, Sanchez-Urrutia L, Medina JM, Sanchez-Medina F and Mayor F (1985) Stimulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) activity by low concentrations of circulating glucose in perfused rat liver. Biochem J 150: 51–58
Nielsen FU, Horsman MR, Daugaard P, Stodkilde-Jorgensen H and Maxwell RJ (1999) Tumor selective in vivo 13C-CP NMR assessment of glycolytic rate under various oxygenation states. Proc Intl Soc Magn Reson Med 2: 1361
Ogawa S, Lee T-M, Nayak AS and Glynn P (1990) Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 14: 68–78
Oikawa H, Al-Hallaq HA, Lewis MZ, River JN, Kovar DA and Karczmar GS (1997) Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn Reson Med 38: 27–32
Ojugo ASE, McSheehy PMJ, McIntyre DJO, McCoy CL, Stubbs M, Leach MO, Judson IR and Griffiths JR (1999) Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous 19F and 31P probes. NMR Biomed 12: 495–504
Okunieff P, Kallinowski F, Vaupel P and Neuringer LJ (1988) Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. J Natl Cancer Inst 80: 745–750
Prysor-Jones RA and Jenkins JS (1981) Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat. J Endocrinol 88: 463–469
Robinson SP, Howe FA and Griffiths JR (1995) Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 33: 855–859
Robinson SP, Rodrigues LM, Ojugo ASE, McSheehy PMJ, Howe FA and Griffiths JR (1997) The response to carbogen breathing in experimental tumour models monitored by gradient-recalled magnetic resonance imaging. Br J Cancer 75: 1000–1006
Robinson SP, van den Boogaart A, Maxwell RJ, Griffiths JR, Hamilton E and Waterton JC (1998) 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models. Br J Cancer 77: 1752–1760
Robinson SP, Collingridge DR, Howe FA, Rodrigues LM, Chaplin DJ and Griffiths JR (1999) Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 12: 98–106
Sansom JM and Wood PJ (1994) 31P MRS of tumour metabolism in anaesthetized vs conscious mice. NMR Biomed 7: 167–171
Sauer LA, Stayman JW and Dauchy RT (1982) Amino acid, glucose and lactic acid utilization in vivo by rat tumors. Cancer Res 42: 4090–4097
Song CW (1998) Modification of blood flow. In: Blood Perfusion and Microenvironment of Human Tumors, Molls M and Vaupel P (eds), pp. 193–207, Springer-Verlag: Berlin, Heidelberg
Stubbs M, Robinson SP, Rodrigues LM, Parkins CS, Collingridge DR and Griffiths JR (1998) The effects of host carbogen (95% O2/5% CO2) breathing on metabolic characteristics of Morris hepatoma 9618a. Br J Cancer 78: 1449–1456
Thomlinson RH and Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539–549
Tozer GM and Griffiths JR (1992) The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism. NMR Biomed 5: 279–289
van den Boogaart A, Howe FA, Rodrigues LM, Stubbs M and Griffiths JR (1995) In vivo 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR Biomed 8: 87–93
Vaupel P, Kallinowski F and Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449–6465
Williams SNO, Rajagopolan B, Adams GE, Hayes D and Brindle KM (1996) A comparative study of tumor vascularization and blood flow in spontaneous and transplanted tumors. Proc Intl Soc Magn Reson Med 2: 1109
Wood PJ, Counsell CJR, Bremner JCM, Horsman MR and Adams GE (1991) The measurement of radiosensitizer-induced changes in mouse tumor metabolism by 31P magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 20: 291–294
Yamaura H and Matsuzawa T (1979) Tumor regrowth after irradiation. An experimental approach. Int J Radiat Biol 35: 201–219
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Robinson, S., Howe, F., Stubbs, M. et al. Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels. Br J Cancer 82, 2007–2014 (2000). https://doi.org/10.1054/bjoc.2000.1144
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1144
Keywords
This article is cited by
-
Advances in methods for assessing tumor hypoxia in vivo: Implications for treatment planning
Cancer and Metastasis Reviews (2006)
-
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours
Cancer Chemotherapy and Pharmacology (2005)